Anticoagulation Forum Inc
EIN: 30474134 · Newton, MA · NTEE: E03
| Metric | Value |
|---|---|
| Total Revenue | $1.2M |
| Total Expenses | $2.4M |
| Net Assets | $5.0M |
Is Anticoagulation Forum Inc Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Anticoagulation Forum Inc
Anticoagulation Forum Inc (EIN: 30474134) is a nonprofit organization based in Newton, MA, classified under NTEE code E03. The organization reported total revenue of $1.2M and total assets of $4.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Anticoagulation Forum Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Anticoagulation Forum Inc is a mid-size nonprofit that has been operating for 22 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 13.7%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $2.5M |
| Total Expenses | $2.4M |
| Surplus / Deficit | +$112K |
| Total Assets | $5.2M |
| Total Liabilities | $192K |
| Net Assets | $5.0M |
| Operating Margin | 4.4% |
| Debt-to-Asset Ratio | 3.7% |
| Months of Reserves | 26.0 months |
Financial Health Grade: A
In 2023, Anticoagulation Forum Inc reported a surplus of $112K with revenue exceeding expenses, holds 26.0 months of operating reserves (strong position), has a debt-to-asset ratio of 3.7% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Anticoagulation Forum Inc's revenue has grown at a compound annual growth rate (CAGR) of 13.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -12.9% | +15.2% | +2.6% |
| 2022 | +19.8% | -14.8% | +14.8% |
| 2021 | +66.6% | +66.1% | +4.9% |
| 2020 | -63.9% | +14.5% | +0.2% |
| 2019 | +272.2% | +36.5% | +163.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2100 |
| IRS Ruling Date | 2004 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Anticoagulation Forum Inc has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Anticoagulation Forum Inc with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $112K, with revenue exceeding expenses.
- Debt-to-asset ratio: 3.7%.
Frequently Asked Questions about Anticoagulation Forum Inc
Is Anticoagulation Forum Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Anticoagulation Forum Inc (EIN: 30474134) insufficient data. 0 red flags identified, 0 strengths noted.
How does Anticoagulation Forum Inc spend its money?
Detailed spending breakdown data is not yet available for Anticoagulation Forum Inc. Check back for updated IRS 990 analysis.
Are donations to Anticoagulation Forum Inc tax-deductible?
Anticoagulation Forum Inc is registered as a tax-exempt nonprofit (EIN: 30474134). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Anticoagulation Forum Inc located?
Anticoagulation Forum Inc is headquartered in Newton, Massachusetts and files with the IRS under EIN 30474134. It is classified under NTEE code E03.
How many years of IRS 990 filings does Anticoagulation Forum Inc have?
Anticoagulation Forum Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.2M in total revenue.
Filing History
IRS 990 filing history for Anticoagulation Forum Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Anticoagulation Forum Inc's revenue has grown by 367.7%, moving from $540K to $2.5M. Total assets increased by 1639.6% over the same period, from $300K to $5.2M. Total functional expenses rose by 507.6%, from $397K to $2.4M. In its most recent filing year (2023), Anticoagulation Forum Inc reported a surplus of $112K, with revenue exceeding expenses. The organization holds $192K in liabilities against $5.2M in assets (debt-to-asset ratio: 3.7%), resulting in net assets of $5.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $2.5M | $2.4M | $5.2M | $192K | — | — |
| 2022 | $2.9M | $2.1M | $5.1M | $170K | — | View 990 |
| 2021 | $2.4M | $2.5M | $4.4M | $317K | — | View 990 |
| 2020 | $1.5M | $1.5M | $4.2M | $72K | — | View 990 |
| 2019 | $4.0M | $1.3M | $4.2M | $36K | — | View 990 |
| 2018 | $1.1M | $948K | $1.6M | $156K | — | View 990 |
| 2017 | $1.2M | $1.0M | $1.5M | $235K | — | View 990 |
| 2016 | $973K | $753K | $1.1M | $27K | — | View 990 |
| 2015 | $774K | $710K | $884K | $13K | — | View 990 |
| 2014 | $752K | $567K | $824K | $13K | — | View 990 |
| 2013 | $644K | $590K | $639K | $14K | — | View 990 |
| 2012 | $459K | $309K | $607K | $161K | — | View 990 |
| 2011 | $540K | $397K | $300K | $5K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $2.5M, expenses of $2.4M, and assets of $5.2M (revenue -12.9% year-over-year).
- 2022: Revenue of $2.9M, expenses of $2.1M, and assets of $5.1M (revenue +19.8% year-over-year).
- 2021: Revenue of $2.4M, expenses of $2.5M, and assets of $4.4M (revenue +66.6% year-over-year).
- 2020: Revenue of $1.5M, expenses of $1.5M, and assets of $4.2M (revenue -63.9% year-over-year).
- 2019: Revenue of $4.0M, expenses of $1.3M, and assets of $4.2M (revenue +272.2% year-over-year).
- 2018: Revenue of $1.1M, expenses of $948K, and assets of $1.6M (revenue -12.9% year-over-year).
- 2017: Revenue of $1.2M, expenses of $1.0M, and assets of $1.5M (revenue +27.7% year-over-year).
- 2016: Revenue of $973K, expenses of $753K, and assets of $1.1M (revenue +25.7% year-over-year).
- 2015: Revenue of $774K, expenses of $710K, and assets of $884K (revenue +2.9% year-over-year).
- 2014: Revenue of $752K, expenses of $567K, and assets of $824K (revenue +16.7% year-over-year).
- 2013: Revenue of $644K, expenses of $590K, and assets of $639K (revenue +40.5% year-over-year).
- 2012: Revenue of $459K, expenses of $309K, and assets of $607K (revenue -15.1% year-over-year).
- 2011: Revenue of $540K, expenses of $397K, and assets of $300K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Anticoagulation Forum Inc:
Data Sources and Methodology
This transparency report for Anticoagulation Forum Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.